California Officials Take Legal Action Against Kratom Manufacturer, Signaling Heightened Enforcement

California Officials Take Legal Action Against Kratom Manufacturer, Signaling Heightened Enforcement

Sacramento, CA – May 2, 2026 – California state officials have filed a legal complaint against a kratom manufacturer, Ashlynn Marketing Group, Inc., operating as Krave, Krave Kratom, and/or Krave Botanicals, for allegedly continuing to produce and sell kratom products despite a state-issued embargo. This significant action by the California Attorney General and Department of Public Health underscores a growing regulatory focus on product safety and compliance within the kratom industry, particularly concerning the potent alkaloid 7-hydroxymitragynine (7-OH).

What Happened

The legal action stems from allegations that Ashlynn Marketing Group, based in Santee, California, violated state law by manufacturing and distributing kratom products after an inspection last year led to an embargo on their materials. State public health officials asserted that the company's continued sales posed a "clear and preventable public health risk" and breached both state and federal law.

Investigators reportedly found evidence that embargoed products had been "moved, tampered with and repackaged," and that manufacturing and distribution persisted. The complaint seeks a court order to halt further production and distribution, mandate the destruction of all embargoed materials, and impose civil penalties. This follows a statewide consumer warning issued by the California Department of Public Health last fall, declaring products containing kratom or 7-OH illegal to manufacture or sell in the state. The FDA has described kratom and its synthetic version, 7-OH, as "dangerous, illegal" opioids, with 7-OH and kratom-derived products linked to addiction, serious health harms, overdose, and death, including at least six overdose fatalities in Los Angeles County in 2025.

Why It Matters to Kratom Merchants and Consumers

This enforcement action sends a stark message across the kratom industry. For merchants, it highlights the increasing scrutiny from state regulators and the severe consequences of non-compliance, including legal battles, product seizures, and significant financial penalties. For consumers, it reinforces the critical importance of purchasing kratom from reputable sources that prioritize rigorous safety standards and transparent testing. The focus on 7-OH, in particular, signals a distinction regulators are drawing between natural kratom leaf and potentially adulterated or highly concentrated derivatives, which are perceived as carrying higher risks.

Compliance Implications for the Kratom Industry

This case underscores that even in the absence of comprehensive federal regulation, states are actively enforcing their own laws and consumer protection acts. Ignoring regulatory warnings or operating without stringent quality control can lead to serious legal repercussions. The industry's "high-risk" classification by payment processors is further justified by incidents like this, emphasizing the need for proactive and robust compliance measures to ensure product integrity and consumer safety.

What High-Risk Merchants Need to Know About COAs, Lab Testing, and Regulatory Compliance

For high-risk kratom merchants, adherence to strict compliance protocols is not merely a best practice; it is essential for survival and legitimacy.

1. Certificates of Analysis (COAs) are Paramount: Every batch of kratom product must be accompanied by a comprehensive COA from an accredited, independent third-party laboratory. This document should be readily available to consumers and regulators.
2. Thorough Lab Testing is Critical: Testing must extend beyond just alkaloid content (mitragynine and 7-OH) to include a full panel of contaminants. This includes heavy metals (arsenic, cadmium, lead, mercury, nickel), microbiological pathogens (Salmonella, E. coli, yeast, and mold), pesticides, and residual solvents. The COA must detail the testing methodologies used.
3. Accredited Laboratories: Ensure your third-party lab holds ISO/IEC 17025 accreditation, which signifies their technical competence and the reliability of their test results.
4. Batch-Specific Traceability: The batch or lot number on the COA must precisely match the product packaging. Generic or outdated COAs are unacceptable and can be a significant red flag for regulators and consumers alike.
5. Adherence to Alkaloid Limits: Be acutely aware of and strictly comply with any state-specific limits on mitragynine and 7-OH content. States like North Carolina and Texas have established clear thresholds for these alkaloids.
6. Truthful Labeling and Marketing: All product labels must be accurate, clearly stating ingredients, serving sizes, and manufacturer information. Avoid making unsubstantiated health claims or marketing products in a way that appeals to minors, as these practices are under increasing scrutiny and can lead to legal action.

This California lawsuit serves as a powerful reminder that the legal and regulatory landscape for kratom is dynamic. Proactive, transparent, and rigorous compliance with evolving standards is the only path forward for responsible kratom merchants.